Happiest Diagnostics receives NABL accreditation

IMT News Desk
IMT News Desk
· 2 min read

Happiest Diagnostics, a unit of Happiest Health, has received accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL). The accreditation was achieved within just two years of inception, reflecting strong governance and early maturity of quality systems. 

Since its inception, Happiest Diagnostics has designed, commissioned and managed its labs in full compliance with NABL guidelines, streamlining the accreditation journey. The company prioritizes precision, reproducibility, and traceability in every diagnostic service, maintaining an unwavering commitment to clinical excellence. 

Ashok Soota, Chairman and Chief Strategy Officer at Happiest Health, said: “Our vision is to create a future-ready diagnostics platform anchored in robust quality systems, adept at managing complex biological data and scalable for cutting-edge testing. This milestone fortifies our base for methodical growth into molecular, genomic, and preventive diagnostics—aligning with medicine’s evolving practice over the next decade.”

Mr. Davis Karedan, Co-Chairman & COO at Happiest Health, added, “As diagnostics becomes central to clinical decision-making, our focus is on delivering an experience that is accurate, transparent, and dependable at every touchpoint—from sample collection to interpretation. This accreditation reinforces our commitment to making advanced diagnostics both clinically reliable and patient-centric.” 

As part of its advanced diagnostics portfolio, Happiest Diagnostics has also introduced Gut Microbiome Testing, leveraging high-throughput sequencing and bioinformatics to analyse over 5 GB of microbial genomic data per sample. This data-intensive test provides clinically relevant insights into digestive health, metabolic balance, immune modulation, and overall wellness, reinforcing the organisation’s focus on preventive, predictive, and personalised diagnostics.

Dr. Bikash Kumar Chaudhury, CEO & Senior Vice President, Happiest Diagnostics, said, “Diagnostics today plays a central role in clinical decision-making across prevention, diagnosis, and long-term care. Receiving NABL accreditation validates the strength of our quality and clinical frameworks, reinforcing confidence in the accuracy and reliability of our reports.” 

Happiest Diagnostics plans to continue investing in automation, quality systems, and advanced diagnostics, with a long-term aspiration to build a future-ready, clinically rigorous, and nationally trusted diagnostic ecosystem.

Read Next

“Patient Trust is Our Real Capital”: How Aarthi   Scans Grew Without Funding
Diagnostics
February 16, 2026

“Patient Trust is Our Real Capital”: How Aarthi Scans Grew Without Funding

V Govindarajan, Founder and Managing Director of Aarthi Scans & Labs, has spent more than two decades proving that advanced diagnostics need not be expensive or limited to metros. Starting with a single centre in Tamil Nadu and no external funding, he built a nationwide network by treating affordability as a core value, not a […]
Article by: Kavita Kiran
National Diagnostics Forum & Awards 2026 held in Mumbai
Diagnostics
January 23, 2026

National Diagnostics Forum & Awards 2026 held in Mumbai

The day-long forum witnessed discussions on critical themes, including precision diagnostics, artificial intelligence adoption etc The 4th Edition of the National Diagnostics Forum & Awards 2026 recently concluded in Mumbai. The day-long forum witnessed discussions on critical themes, including precision diagnostics, artificial intelligence adoption, public-private partnerships, and the business dynamics driving consolidation in the sector. […]
Article by: IMT News Desk
Mahajan Imaging & Labs introduces Alzheimer’s Diagnostics
Diagnostics
January 21, 2026

Mahajan Imaging & Labs introduces Alzheimer’s Diagnostics

Includes Alzheimer’s blood biomarker testing using the pTAU217/βAmyloid1-42 ratio along with cognitive health and genetic risk panels Mahajan Imaging & Labs, a leading chain of advanced diagnostic centres in India, has expanded its Alzheimer’s diagnostic capabilities with the introduction of an AI-integrated blood biomarker test, supported by a structured PET and MRI imaging pathway, offered […]
Article by: IMT News Desk
Metropolis Healthcare launches Centre of Genomics to scale precision diagnostics and advance research
Diagnostics
January 15, 2026

Metropolis Healthcare launches Centre of Genomics to scale precision diagnostics and advance research

The Centre of Genomics is designed to deliver clinically actionable genomic insights across the care continuum, supporting multiple high-impact clinical specialties Metropolis Healthcare has announced the launch of its Centre of Genomics. The Centre of Genomics is designed to deliver clinically actionable genomic insights across the care continuum, supporting multiple high-impact clinical specialties. As part […]
Article by: IMT News Desk